1. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (22nd February 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study. (30th August 2013) Authors: Berneburg, M.; Herzinger, T.; Rampf, J.; Hoetzenecker, W.; Guenova, E.; Meisner, C.; Maetzke, J.; Schaefer, T.; Eberlein, B.; Scharffetter‐Kochanek, K.; Rocken, M. Journal: British journal of dermatology Issue: Volume 169:Number 3(2013:Sep.) Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine. Issue 5 (8th March 2016) Authors: Bieber, T.; Akdis, C.; Lauener, R.; Traidl‐Hoffmann, C.; Schmid‐Grendelmeier, P.; Schäppi, G.; Allam, J.‐P.; Apfelbacher, C.; Augustin, M.; Beck, L.; Biedermann, T.; Braun‐Fahrländer, C.; Chew, F. T.; Clavel, T.; Crameri, R.; Darsow, U.; Deleuran, M.; Dittlein, D.; Duchna, H.‐W.; Eichenfeld, L. Journal: Allergy Issue: Volume 71:Issue 5(2016:May) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Individualized treatment approaches for Langerhans cell histiocytosis. (1st June 2018) Authors: Roider, E.; Signer, C.; Fehrenbacher, B.; Metzler, G.; Schaller, M.; Kamarachev, J.; Kerl, K.; Balabanov, S.; Jochum, W.; Hoetzenecker, W.; Cozzio, A.; French, L.E.; Dummer, R.; Guenova, E. Journal: British journal of dermatology Issue: Volume 178:Number 6(2018) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Individualized treatment approaches for Langerhans cell histiocytosis. (23rd March 2018) Authors: Roider, E.; Signer, C.; Fehrenbacher, B.; Metzler, G.; Schaller, M.; Kamarachev, J.; Kerl, K.; Balabanov, S.; Jochum, W.; Hoetzenecker, W.; Cozzio, A.; French, L.E.; Dummer, R.; Guenova, E. Journal: British journal of dermatology Issue: Volume 178:Number 6(2018) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ingenol mebutate for mycosis fungoides. (18th August 2019) Authors: Ignatova, D.; Chang, Y.‐T.; Hoetzenecker, W.; Guenova, E. Journal: British journal of dermatology Issue: Volume 181:Number 5(2019) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ingenol mebutate for mycosis fungoides. (1st November 2019) Authors: Ignatova, D.; Chang, Y.‐T.; Hoetzenecker, W.; Guenova, E. Journal: British journal of dermatology Issue: Volume 181:Number 5(2019) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Interferon alfa‐2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement. (1st December 2019) Authors: Doerschner, M.; Pekar‐Lukacs, A.; Messerli‐Odermatt, O.; Dommann‐Scherrer, C.; Rütti, M.; Müller, A.M.; Nair, G.; Kamarachev, J.; Kerl, K.; Beer, M.; Messerli, M.; Frauenknecht, K.; Haralambieva, E.; Hoetzenecker, W.; French, L.E.; Guenova, E. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗